OLMA OLEMA PHARMACEUTICALS INC Investor Conferences 8-K Filing 2024 - Corporate Presentation Olema Pharmaceuticals announced a corporate presentation and plans to present non-clinical data for OP-3136 at an upcoming symposium, with an IND application expected in Q4 2024 and a Phase 1/2 study starting in 2025.Get access to all SEC 8-K filings of the OLEMA PHARMACEUTICALS INC